{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:40:42Z","timestamp":1792806042632,"version":"4.5.0"},"reference-count":44,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ulsan University Hospital Research Grant","award":["UUH-2019-05"],"award-info":[{"award-number":["UUH-2019-05"]}],"id":[{"id":"https:\/\/ror.org\/03sab2a45","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Extranodal marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) type is the most common subtype of the ocular adnexal lymphoma. Despite its excellent prognosis, some patients experience partial remission or progressive disease. We aimed to evaluate clinicopathologic differences in the treatment responder group by comparing complete remission (CR) and non-complete remission (non-CR). Materials and Methods: This study retrospectively reviewed 48 patients who were diagnosed with ocular adnexal MALT lymphoma at Ulsan University Hospital between March 2002 and August 2018. Patients who were followed up for less than 6 months were excluded. Histologic and clinical features were analyzed. The patients were divided into two groups: CR and non-CR. Results: Among the 48 patients, 33 achieved CR and 15 achieved non-CR during the median follow-up period of 40.00 months (range, 7\u2013109 months). In univariable analysis, more patients tend to undergo treatment in the CR group, and post-radiotherapy (post-RT) SUVmax, PET and serum lactate dehydrogenase (LDH) levels were higher in the non-CR group (p = 0.043, p = 0.016, and p = 0.042, respectively). In a multivariable analysis, only application of treatment, including radiotherapy or chemotherapy with immunotherapy, was related to CR (odd ratio 7.301, 95% confidence interval 1.273\u201341.862, p = 0.026). In subgroup analysis according to the site of involvement, none of the variables were significant except for the post-RT SUVmax of PET and level of serum LDH in the non-conjunctiva group (p = 0.026, and p = 0.037, respectively). Seven (14.6%) patients had a recurrence, and those with a recurring site other than the primary site had a higher Ki-67 labeling index, although it was not statistically significant (9.56% vs. 18.00%, p = 0.095). Conclusions: Although belonging to the early stages, the non-CR rate was high in patients with high serum LDH levels, and recurred patients had higher Ki-67. Thus, considering active treatment is recommended in this group of patients.<\/jats:p>","DOI":"10.3390\/medicina58060818","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T11:45:44Z","timestamp":1655466344000},"page":"818","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinicopathologic Characteristics Associated with Prognosis in Ocular Extranodal Marginal Zone B Cell Lymphoma"],"prefix":"10.3390","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1569-6592","authenticated-orcid":false,"given":"Soyeon","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Pathology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 05505, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjung","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 05505, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seol Hoon","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 05505, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6014-7977","authenticated-orcid":false,"given":"Jae-Cheol","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 05505, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0406-4469","authenticated-orcid":false,"given":"Seoung Wan","family":"Chae","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0462-6081","authenticated-orcid":false,"given":"Ju-Hyang","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ajou University Medical Center, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jeong","family":"Cha","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 05505, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"key":"ref_1","first-page":"109","article-title":"Conjunctival Tumors: Review of Clinical Features, Risks, Biomarkers, and Outcomes\u2014The 2017 J. Donald M. Gass Lecture","volume":"6","author":"Shields","year":"2017","journal-title":"Asia-Pac. J. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.22608\/APO.2016209","article-title":"Lymphoproliferative Tumors of the Ocular Adnexa","volume":"6","author":"Verdijk","year":"2017","journal-title":"Asia-Pac. J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ajo.2018.11.002","article-title":"Orbital Lymphoma-An International Multicenter Retrospective Study","volume":"199","author":"Olsen","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/archopht.125.12.1668","article-title":"Lymphoproliferative diseases of the ocular adnexa in Korea","volume":"125","author":"Oh","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.pas.0000213350.49767.46","article-title":"Lymphoma of the ocular adnexa: A study of 353 cases","volume":"31","author":"Ferry","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/jamaophthalmol.2015.6122","article-title":"Conjunctival Lymphoma\u2014An International Multicenter Retrospective Study","volume":"134","author":"Kirkegaard","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5301\/ejo.5000224","article-title":"Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor","volume":"23","author":"Graue","year":"2013","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/aol-20-28","article-title":"Epidemiology of Marginal Zone Lymphoma","volume":"5","author":"Cerhan","year":"2021","journal-title":"Ann. Lymphoma"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"Stefanovic","year":"2009","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3109\/10428194.2014.979415","article-title":"Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy","volume":"56","author":"Parikh","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13014-020-1477-8","article-title":"Radiotherapy alone for stage IE ocular adnexal mucosa-associated lymphoid tissue lymphomas: Long-term results","volume":"15","author":"Niwa","year":"2020","journal-title":"Radiat. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.5858\/2008-132-1405-MFOLOT","article-title":"Morphologic features of 115 lymphomas of the orbit and ocular adnexa categorized according to the World Health Organization classification: Are marginal zone lymphomas in the orbit mucosa-associated lymphoid tissue-type lymphomas?","volume":"132","author":"Lagoo","year":"2008","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/bjophthalmol-2020-315875","article-title":"Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: Validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM classification","volume":"105","author":"Kwon","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_16","first-page":"3727","article-title":"Clinicopathologic Assessment of Ocular Adnexal Lymphoproliferative Lesions at a Tertiary Eye Hospital in Iran","volume":"17","author":"Nozarian","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s10384-017-0513-1","article-title":"Immunophenotypic profiles for distinguishing orbital mucosa-associated lymphoid tissue lymphoma from benign lymphoproliferative tumors","volume":"61","author":"Ueda","year":"2017","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/modpathol.3880366","article-title":"Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: Characterization of malt lymphoma and reactive lymphoid hyperplasia","volume":"14","author":"Mannami","year":"2001","journal-title":"Mod. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Qu, X.L., Hei, Y., Kang, L., Yang, X.J., Wang, Y., Lu, X.Z., Xiao, L.H., and Yang, G. (2017). Establishment of a combination scoring method for diagnosis of ocular adnexal lymphoproliferative disease. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0160175"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40662-019-0151-4","article-title":"Bilateral benign reactive lymphoid hyperplasia of the conjunctiva: A case treated with oral doxycycline and review of the literature","volume":"6","author":"Klavdianou","year":"2019","journal-title":"Eye Vis."},{"key":"ref_21","first-page":"200","article-title":"Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: Absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup","volume":"90","author":"Petit","year":"2005","journal-title":"Haematologica"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hon.2563","article-title":"Prognostic role of baseline (18) F-FDG PET\/CT parameters in MALT lymphoma","volume":"37","author":"Albano","year":"2019","journal-title":"Hematol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1182\/blood-2008-01-132415","article-title":"The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment","volume":"112","author":"Wormhoudt","year":"2008","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/modpathol.2013.106","article-title":"Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression","volume":"26","author":"Brenner","year":"2013","journal-title":"Mod. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s12185-020-02968-w","article-title":"Treatment outcomes of IgG4-producing marginal zone B-cell lymphoma: A retrospective case series","volume":"112","author":"Sumii","year":"2020","journal-title":"Int. J. Hematol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lee, M.J., Kim, N., Choe, J.Y., Khwarg, S.I., Jeon, Y.K., Choung, H.K., and Kim, J.E. (2015). Clinicopathological Analysis of Ocular Adnexal Extranodal Marginal Zone B-Cell Lymphoma with IgG4-Positive Cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131458"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1136\/jcp.2010.082156","article-title":"Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells","volume":"63","author":"Kubota","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.2147\/OTT.S242852","article-title":"The Expression of IgG and IgG4 in Orbital MALT Lymphoma: The Similarities and Differences of IgG4-Related Diseases","volume":"13","author":"Li","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3109\/10428194.2013.823494","article-title":"Close pathogenetic relationship between ocular immunoglobulin G4-related disease (IgG4-RD) and ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma","volume":"55","author":"Nakayama","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ohno, K., Sato, Y., Ohshima, K., Takata, K., Miyata-Takata, T., Takeuchi, M., Gion, Y., Tachibana, T., Orita, Y., and Ito, T. (2015). A subset of ocular adnexal marginal zone lymphomas may arise in association with IgG4-related disease. Sci. Rep., 5.","DOI":"10.1038\/srep13539"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2559.2011.04089.x","article-title":"Ocular adnexal IgG4-related disease: Comparative analysis with mucosa-associated lymphoid tissue lymphoma and other chronic inflammatory conditions","volume":"60","author":"Go","year":"2012","journal-title":"Histopathology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10428199909145705","article-title":"Molecular genetics of extranodal marginal zone (MALT-type) B-cell lymphoma","volume":"35","author":"Bertoni","year":"1999","journal-title":"Leuk. Lymphoma"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s11658-020-00228-7","article-title":"The usefulness of lactate dehydrogenase measurements in current oncological practice","volume":"25","author":"Forkasiewicz","year":"2020","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2141.2010.08429.x","article-title":"Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): Single institution experience in a large cohort of patients","volume":"152","author":"Bayraktar","year":"2011","journal-title":"Br. J. Haematol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/blood-2017-03-771915","article-title":"A MALT lymphoma prognostic index","volume":"130","author":"Thieblemont","year":"2017","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000070290","article-title":"18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma","volume":"64","author":"Hoffmann","year":"2003","journal-title":"Oncology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1080\/10428194.2017.1298754","article-title":"18F-FDG PET\/CT and extragastric MALT lymphoma: Role of Ki-67 score and plasmacytic differentiation","volume":"58","author":"Albano","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s10147-019-01481-3","article-title":"Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis","volume":"24","author":"Masuda","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/bjophthalmol-2019-314008","article-title":"International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma","volume":"104","author":"Hindso","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00277-004-0914-3","article-title":"Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa","volume":"84","author":"Lee","year":"2005","journal-title":"Ann. Hematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood-2016-05-714584","article-title":"Long-term course of patients with primary ocular adnexal MALT lymphoma: A large single-institution cohort study","volume":"129","author":"Desai","year":"2017","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2013.11.235","article-title":"Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: A long-term outcome in 86 patients with 104 treated eyes","volume":"88","author":"Harada","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1136\/bjophthalmol-2018-312836","article-title":"Refractory follicular conjunctival lesions: Overlook as just inflammation or not?","volume":"103","author":"Jung","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-9378-7-8","article-title":"Chlamydia psittaci in ocular adnexa MALT lymphoma: A possible role in lymphomagenesis and a different geographical distribution","volume":"7","author":"Collina","year":"2012","journal-title":"Infect. Agents Cancer"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/6\/818\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:34:07Z","timestamp":1760139247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/6\/818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["medicina58060818"],"URL":"https:\/\/doi.org\/10.3390\/medicina58060818","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]}}}